A detailed history of Xtx Topco LTD transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 16,723 shares of KZR stock, worth $9,532. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,723
Previous 44,019 62.01%
Holding current value
$9,532
Previous $41,000 63.41%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.8 - $1.05 $21,836 - $28,660
-27,296 Reduced 62.01%
16,723 $15,000
Q4 2023

Feb 13, 2024

SELL
$0.72 - $1.15 $19,913 - $31,806
-27,658 Reduced 38.59%
44,019 $41,000
Q3 2023

Nov 13, 2023

SELL
$1.08 - $2.54 $24,803 - $58,333
-22,966 Reduced 24.27%
71,677 $85,000
Q2 2023

Aug 14, 2023

BUY
$2.31 - $3.06 $218,625 - $289,607
94,643 New
94,643 $231,000
Q3 2022

Nov 14, 2022

BUY
$7.99 - $10.75 $146,193 - $196,692
18,297 New
18,297 $158,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $39M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.